Ravi Vij is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 42 publications with 527 citations (h-index 8); ClinicalTrials.gov lists 16 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 Forest Park Ave
Div Im Bone Marrow Transplant, 5th, 6th, 8th Fl
Saint Louis, MO 631082114
Telephone
314-454-8304Registry record last updated 17 Apr 2025.
Clinical trials
- Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
Sponsor: Washington University School of Medicine
- 64Cu-LLP2A for Imaging Hematologic Malignancies
Sponsor: Washington University School of Medicine
- Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20257 payments
- PFIZER INC.Program year20252 payments
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.2%CD38-directed Cytolytic Antibody55.5%Daratumumab100%Part B, office-administered≥24 patientsThalidomide Analog3.3%Lenalidomide39%Pomalyst33%Revlimid28%Part D≥22 patients+ 2 more classes in this area
Metabolism & gastrointestinal
23.1%Other antiemetics18.3%Fosaprepitant100%Part B, office-administered≥13 patientsSerotonin-3 Receptor Antagonist3.7%Palonosetron hcl56%Granisetron hydrochloride37%Ondansetron Hcl4%Ondansetron Odt3%Part D + Part B<11 patients+ 5 more classes in this area
Sensory organs
7.8%Corticosteroid7.8%Dexamethasone sodium phosphate86%Dexamethasone14%Part D + Part B≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma <scp>NOS</scp>
British Journal of Haematology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”